Prospective Non-randomized Multicenter Study to Assess the Efficacy Response Duration and Toxicity of RFC as First-line Treatment and R as Maintenance Treatment, in Patients Diagnosed of Follicular Non Hodgkin Lymphoma.
Phase of Trial: Phase IV
Latest Information Update: 20 May 2010
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Fludarabine
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 20 May 2010 New trial record